Recorded Chinese product: 甲磺酸酚妥拉明胶囊甲磺酸酚妥拉明胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 上海丽珠制药有限公司Chinese legal name: 上海丽珠制药有限公司
主要成分Active Ingredients
- 酚妥拉明Fentuo Laming
药物知识说明
酚妥拉明是一种在国家药监局注册认定的药品。该药品含有酚妥拉明-1f4bf4ba等成分。
该药品关联的活性成分包括：酚妥拉明Fentuo Laming。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：上海丽珠制药有限公司Chinese legal name: 上海丽珠制药有限公司。
您可以探索含有相同成分的其他药品：酚妥拉明-1f4bf4ba成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 甲磺酸酚妥拉明胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 酚妥拉明Fentuo Laming.
Manufacturers recorded for this product: 上海丽珠制药有限公司Chinese legal name: 上海丽珠制药有限公司.
Explore other medicines containing the same ingredient: 酚妥拉明 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 甲磺酸酚妥拉明胶囊Recorded Chinese product: 甲磺酸酚妥拉明胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 40mg*6片40 mg × 6 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 上海丽珠制药有限公司Chinese legal name: 上海丽珠制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20030150
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20030150
Manufacturer
Chinese legal name: 上海丽珠制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
40 mg × 6 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H20030150
生产企业
上海丽珠制药有限公司(国产)
适应症
用于男性勃起功能障碍的治疗。
用法用量
口服，性活动前30分钟服用，每次一粒（40mg），一日用药不超过1次。
不良反应
常见有鼻塞、头痛、头晕、面色潮红、消化不良、腹泻、尿道感染、乏力、胸闷、一次性轻微幻觉和皮疹；少数患者可有心悸、心动过速、心律失常、乏力、恶心呕吐、低血压；极个别患者可能直立性低血压。
禁忌
低血压、严重动脉硬化、心脏器质性损害、肾功能不全者，胃与十二指肠溃疡患者及对本品过敏者忌用。
注意事项
1.胃炎、冠状动脉供血不足患者慎用；
2.忌与铁剂配伍；
3.忌与降压药同服；
4.服药期间，不得驾驶车、船或操作危险的机器；
5.请置于儿童触不到处。
贮藏
密封，置阴凉处。
规格
40mg*6片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.